268 related articles for article (PubMed ID: 10726048)
1. The Leiden mutation of coagulation factor V in Hungarian SLE patients.
Regéczy N; Lakos G; Balogh I; Ajzner E; Kiss E; Szegedi G
Clin Appl Thromb Hemost; 2000 Jan; 6(1):41-5. PubMed ID: 10726048
[TBL] [Abstract][Full Text] [Related]
2. Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.
Topaloglu R; Akierli C; Bakkaloglu A; Aydintug O; Ozen S; Besbas N; Ozcelik T
Clin Rheumatol; 2001; 20(4):259-61. PubMed ID: 11529632
[TBL] [Abstract][Full Text] [Related]
3. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
4. Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?
Berman H; Ugarte-Gil MF; Espinosa G; Tàssies D; Monteagudo J; Reverter JC; Cervera R
Clin Exp Rheumatol; 2013; 31(6):926-32. PubMed ID: 24093662
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.
Fijnheer R; Horbach DA; Donders RC; Vilé H; von Oort E; Nieuwenhuis HK; Gmelig-Meijling FH; de Groot PG; Derksen RH
Thromb Haemost; 1996 Oct; 76(4):514-7. PubMed ID: 8902988
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis.
Uthman I; Khalil I; Sawaya R; Taher A
Clin Rheumatol; 2004 Aug; 23(4):362-3. PubMed ID: 15293102
[TBL] [Abstract][Full Text] [Related]
7. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutation.
Regéczy N; Balogh I; Lakos G; Zeher M; Bodolay E; Szücs G; Kiss E; Ajzner E; Szegedi G
Haematologia (Budap); 2000; 30(1):35-9. PubMed ID: 10841323
[TBL] [Abstract][Full Text] [Related]
10. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
11. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
13. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
14. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
16. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
[TBL] [Abstract][Full Text] [Related]
17. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome and factor V Leiden. Three cases with recurrent venous thrombosis.
Guis-Sabatier S; Roudier J; Arnoux D; Rochwerger A; Roux H; Mattei JP
Joint Bone Spine; 2000; 67(2):134-6. PubMed ID: 10769107
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
20. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
